Særlige kompetencer
2011, Cand.med., Aarhus Universitet
2019, Speciallæge i dermato-venerologi
Speciallæge/afdelingslæge, Hud- og Kønssygdomme, Aarhus Universitetshospital, 2019-2023
Speciallæge/afdelingslæge, Klinisk Forskningsenhed, Hud- og Kønssygdomme, Aarhus Universitetshospital, 2019-2023
Reservelæge, intro- og hoveduddannelse, Hud- og Kønssygdomme, AUH-OUH-AUH, 2014-2019
Konsulent (hudsygdomme), Mølholm Privathospital, 2018-2019
Reservelæge, sideuddannelse, Infektionsmedicinsk afdeling Q, Aarhus Universitetshospital, 2015
Reservelæge, introuddannelse, Nyremedicinsk afdeling, Herlev Hospital, 2012-2013
Reservelæge, Nyremedicinsk afdeling, Aalborg Universitetshospital, 2012
Praksislæge og vagtlæge, Kommunelegen i Suldal, Norge, 2012
Praksislæge, Læge- og sygeplejeklinikken, Hadsund, 2012
Reservelæge, Rheumatologisk afdeling, Frederiksberg Hospital, 2011-2012
Reservelæge, Ortopædkirurgisk afdeling, Hvidovre Hospital, 02/2011 – 08/2011
Vikar for reservelæge, Aalborg Psykiatriske Hospital, 2010
Vikar for reservelæge, Nyremedicinsk afdeling og Endokrinologisk afdeling, Aalborg Universitetshospital, 2009-2010
Vikar for reservelæge, Nyremedicinsk afdeling, Aalborg Universitetshospital, 2009
Akademisk arbejde
Fage SW, Muris J, Jakobsen SS, Thyssen JP. Titanium: a review on exposure, release, penetration, allergy, epidemiology and clinical reactivity. Contact Dermatitis. 2016 Jun;74(6):323-45
Fage SW, Faurschou A, Thyssen JP. Copper hypersensitivity. Contact Dermatitis. 2014 Oct;71(4):191-201.
Simon W. Fage. Metal Allergy: Copper. Metal Allergy: From Dermatitis to Implant and Device Failure. Eds. Jennifer K. Chen and Jacob P. Thyssen. ISBN: 978-3-319-58502-4 (11 pages)
Fage SW, Iftner T, Thyssen JP, Kjaer SK. Filaggrin, Human Papillomavirus, and the Cervix. Filaggrin. Basic Science, Epidemiology, Clinical Aspects and Management (Thyssen and Maibach, eds.), Springer 2014 (p. 333-342)
Fage SW, Arvesen KB, Olesen AB. Abatacept Improves Skin-score and Reduces Lesions in Patients with Localized Scleroderma: A Case Series. Acta Derm Venereol. 2018 Apr 16;98(4):465-466
Fage SW, Olsen AB. Dysthrophic calcification in Systemic Sclerosis – Intralesional Injections of Sodium Thiosulfate may have significant Positive Effects on your patients. Medical Research Archives vol 8 issue 5. May 2020
Loft N, Bregnhøj A, Fage S, Nielsen CH, Enevold C, Zachariae C, Iversen L, Skov L. Effectiveness of brodalumab after previous treatment failure of interleukin-17A inhibitors in patients with psoriasis. Dermatol Ther. 2021 Aug 21:e15106. doi: 10.1111/dth.15106. Epub ahead of print. PMID: 34418225.
Andersen SM, Fage S, Rubak SL, Holm M, Jensen JMB, Mogensen T, Deleuran M. Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome Manifesting as Lymphocytic Interstitial Pneumonia and Treatment-Resistant Bullous Pemphigoid. Pediatr Allergy Immunol Pulmonol. 2021 Jun;34(2):76-79. doi: 10.1089/ped.2020.1307. PMID: 34143686; PMCID: PMC8329723.
Mette Gyldenløve; Howraman Meteran; Jennifer Astrup Sørensen; Simon Fage; Yiqiu Yao; Jesper Lindhardsen; Christoffer Valdemar Nissen; Tanja Todberg; Simon Francis Thomsen; Lone Skov; Claus Zachariae; Lars Iversen; Mia-Louise Nielsen; Alexander Egeberg. Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis – a randomized controlled trial (PSORRO). (under review, Lancet)
Simon Fage, Claus Johansen. Severe and therapeutic challenging oral erosive lichen planus treated with oral roflumilast. (accepteret, Clinical and Experimental Dermatology)
Klinisk forskning
EXP-1373, Leo Pharma (kutan lupus erythematosus) (primary investigator)
RD.06.SPR.202685, Galderma (prurigo nodularis) (primary investigator)
RD.06.SPR.202699, Galderma (prurigo nodularis) (primary investigator)
JAHN(7), Lilly (atopisk dermatitis)
M16-045, AbbVie (atopisk dermatitis)
M18-891, AbbVie (atopisk dermatitis)
AIN457 (SUNRISE), Novartis (hidrosadenitis suppurativa)
INCB 54707-203, Incyte corp. (hidrosadenitis suppurativa)
LP0133-1273, Leo Pharma (kronisk håndeksem)
PsoPET2, Leo Pharma (psoriasis)
2018-PSO-IL17R, investigator initiated, LEO Pharma (psoriasis)
SMR-3612, Almirall (psoriasis)
CUDC 305, Innovaderm Research Inc. (psoriasis)
STEPIn (CAIN457A2322), Novartis (psoriasis)
CLOU064A2201, Novartis (kronisk nældefeber)
CLOU064A2201E1 (ext.), Novartis (kronisk nældefeber)
HS0003, ucb (hidrosadenitis suppurativa)
PSORRO, investigator initiated (psoriasis)
Delta 2+3, Leo Pharma (kronisk håndeksem)
M23-696, Abbvie (atopisk dermatitis)